Feng Ren
Chief Executive Officer at Insilico Medicine Cayman TopCo
Feng Ren active positions
| Companies | Position | Start | End |
|---|---|---|---|
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Director/Board Member | 2021-05-31 | - |
| Chief Executive Officer | 2022-05-31 | - | |
| Chief Tech/Sci/R&D Officer | 2021-01-31 | - |
Career history of Feng Ren
Training of Feng Ren
| University of Science & Technology of China | Undergraduate Degree |
| National University of Singapore | Graduate Degree |
| Harvard University | Doctorate Degree |
Statistics
International
| Hong Kong | 2 |
| China | 2 |
| Singapore | 2 |
Operational
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Commercial Services |
- Stock Market
- Insiders
- Feng Ren
- Experience
